Pharma Jonpi .
15 junio 2020
Jazz Pharmaceuticals Announces U.S. FDA Accelerated Approval of Zepzelca™ (lurbinectedin) for the Treatment of Metastatic Small Cell Lung Cancer .
‹
›
Inicio
Ver versión web